Proteins 3 - misfolding & disease 09/06 Traish Flashcards
1
Q
T/F protein misfolding aka conformational disease can arise from reduced intracellular concentrations or protein aggregates
A
true
2
Q
what are pathological protein aggregates called intracellularly?
A
intracellular inclusions
3
Q
what are pathological protein aggregates called extracellularly?
A
amyloid fibrils or plaques
4
Q
an amyloid fibril is…
A
a pathological extracellular protein aggregate of plaque
5
Q
as a polypeptide is synthesized, is it initially folded or unfolded?
A
unfolded
6
Q
what are two likely paths of a synthesized protein that remains unfolded in the cell?
A
it is likely to be degraded, reducing the proteins intracellular concentration
-or- it may become disordered and aggregate
7
Q
what are the consequences of amyloid fibril build-up?
A
cellular damage and toxicity
8
Q
T/F regions of of a misfolded protein can contribute to greater misfolding of the native protein molecules through protein-protein interactions
A
true
9
Q
which of the following can predispose protein misfolding:
- increased production of pp with misfolding
- mutations
- biochemical stress (delta pH or oxidative stress
- failure of chaperone systems
- aging
A
all of the above
10
Q
This protein and this molecule commonly direct misfolded proteins into the proteosomes
A
HSP (heat shock proteins)
ubiquitin
11
Q
T/F proteosome enzymatic machinery regenerates ubiquitin after degrading misfolded proteins
A
true
12
Q
what do proteosomes degrade misfolded proteins into?
A
small peptides
13
Q
what does heat shock protein have to do with protein misfolding?
A
HSP disaggregates compact aggregates and can direct them to proteosomes with the help of ubiquitin, or can restore proper folding with assistance of other HSPs (chaperones)
14
Q
amyloidosis signifies
A
pathological build-up of amyloid fibers (misfolded protein aggregates)
15
Q
T/F build up of amyloid proteins (amyloidosis) can cause neurodegenerative disorders
A
true
16
Q
T/F amyloid proteins must be toxic to cause cellular damage
A
false – non-toxic amyloid fibers can cause damage by forming obstructive plaques
17
Q
T/F it has been suggested that up to 25% of all human disease is attributed to protein misfolding
A
false – up to 50% of all human disease is attributed to protein misfolding
18
Q
mad cow is a type of
A
spongiform encephalopathy
19
Q
“encephalopathy” signifies…
A
a disorder/disease of the brain
20
Q
T/F Alzheimer’s, spongiform encephalopathies, Parkinson’s, Amyotrophic lateral sclerosis, certain dimentias, Creutzfelt-Jakob’s, Cystic fibrosis, and Huntington’s disease are all associated with protein misfolding and aggregation
A
true
21
Q
cystic fibrosis is characterized by
A
abnormal transport of chloride and sodium across an epithelium, leading to thick, viscous secretions
22
Q
abnormal transport of chloride and sodium across an epithelium, leading to thick, viscous secretions is characteristic of this disease
A
cystic fibrosis
23
Q
list 3 hypothesis for the mechanism of protein misfolding diseases
A
-loss of protein function
-inflammation in response to misfolded proteins
-gain of toxic protein activity
(all lead to cellular / neuronal degeneration)
24
Q
this disease produces gradual memory failure and progresses slowly to involve many cognitive impairments and shortens life expectancy
A
Alzheimer’s disease
25
the pathology of Alzheimer's presents with extracellular plaques comprised of how many aa residues?
40 and 42 aa residue polypeptides
26
what are the 40 and 42 aa residue polypeptides that cause Alzheimer's called?
beta-amyloid proteins (ABeta)
27
modified forms of this microtubule-associated protein compose the interneuronal tangles in Alzheimers patients
tau
28
what is the protein that produces the protein that forms the extracellular plaques observed in Alzheimer's patients?
amyloid precurser protein APP
-produces-
beta amyloid protein ABeta
29
APP in the context of Alzheimer's refers to...
amyloid precurser protein
30
ABeta in the context of Alzheimer's refers to...
beta-amyloid protein
31
how does APP produce ABeta in the context of Alzheimer's
APP is proteolytically cleaved by a family of proteases known as secretases
32
mutations in several genes, incluing APP, presenilin 1, and presenilin 2 contribute to the development of AD by...
increasing cerebral b-amyloid production (APP must be cleaved by presenilin / g-secretase complex to form ABeta40 and 42)
33
inheritance of this polymorphism enhances b-amyloid accumulation
apolipoprotein E4 polymorphism
34
what is a polymorphism?
an occurrence of multiple clearly distinct phenotypes in the same population (e.g. male/female, blue/brown eyes, etc)
35
how does apolipoprotein E4 polymorphism contribute to Alzheimer's?
it increases b-amyloid accumulation
36
ABeta42 and ABeta40 refer to...
b-amyloid proteins 42 and 40
37
in Alzheimer's patients, is the imbalance in ABeta production and clearance the result of genetic alterations, environmental alterations, or both?
both -- genetic and environmental alterations in protein synthesis and processing machinery
38
overproduction and hyperphosphorylation of tau results in these types of aggregate formations in Alzheimer's patients:
paired helical filaments (PHFs)
39
in the context of Alzheimer's, what is PHF?
PHF is a paired helical filament, the aggregate formation that results from the overproduction and hyperphosphorylation of tau protein
40
a "poly-Q" containing protein stands for...
a protein that contains multiple glutamine residues
41
what is the threshold of glutamine residues that predisposes a poly-Q protein to b-aggregate and cause Alzheimer's?
>35 Q residues
42
T/F >45 poly-Q proteins are predisposed to aggregate and cause Alzheimer's
technically true... but the threshold is >35 Q residues
43
>35 __ residues can predispose a protein to aggregate and cause Alzheimer's?
Q glutamine gln
44
>35 poly-Q proteins may aggregate and cause Alzheimer's if they adopt ___ or ___ secondary structures, but not ___ secondary structures
random coil or hairpin conformations ~> aggregate
| helical conformations - nonpathological
45
T/F peptides proteolytically cleaved from APP precipitate as ABeta structures in equilibrium with oligomers, which may eventually redissolve into the membrane
true
46
what are 2 fates of ABeta proteins proteolytically cleaved from APP?
- ABeta proteins may pathologically aggregate
| - ABeta proteins may form oligomers that can redissolve into the membrane
47
plaques in alzheimer's patients are generated by deposition of what proteins?
b-amyloid proteins (ABeta)
48
these proteins are proteolytic products of cleavage of APP
b-amyloid proteins (ABeta)
49
where does APP exist in the cell and is it a glycoprotein or a proteoglycan?
it is a transmembrane cell surface glycoprotein
50
what is the predominant isoform of APP in the brain?
APP 695
51
what are the three proteases that cleave APP?
alpha, beta, and gamma secretase
52
hydrolytic cleavage of APP by which 2 secretases results in ABeta40 and ABeta42?
beta secretase, then gamma secretase
53
hydrolytic cleavage of APP by which 2 secretases results in aggregates and plaque formation?
beta secretase, then gamma secretase
54
hydrolytic cleavage of APP by which 2 secretases results in a non-toxic soluble peptide (probably)?
cleavage by alpha secretase, then gamma secretase, results in non-toxic p3 protein
55
what is the result of the hydrolytic cleavage of APP by a- and g-secretase?
p3 protein, which is degraded properly and causes no apparent problems (although there are recent reports to the contrary...)
56
what is the result of the hydrolytic cleavage of APP by b- and g-secretase?
b-amyloid proteins (ABeta40 and 42), which migrate outside the cell and give rise to fibrils
57
do b-amyloid proteins give rise to plaques inside the cell or outside the cell?
outside -- after cleavage from APP, ABeta40 and 42 migrate outside the cell and give rise to fibrils
58
APP proteins exist on plasma membranes and also...
intracellular vesicles, such as endosomes
59
T/F soluble oligomers formed by ABeta proteins may either ___ (nonpathologic) or ___ (neurodegenerative consequence)
- re-dissolve into the membrane
- diffuse into synaptic clefts and interfere with synaptic function (by an unknown mechanism) and then aggregate into plaques disturbing axons and dendrites
60
in Alzheimer's, how do the pathological ABeta and tau pathways intersect?
ABeta aggregates activate kinases in the neuronal cytoplasm, producing hyperphosphorylation of the microtubule associated protein, tau, and its polymerization into insoluble filaments that aggregate and neurofibrillary tangles
61
what is the immune response to ABeta and tau aggregates?
activated neuroglia (microglia and reactive astrocytes) around the plaques participate in a local inflammatory response that may contribute to neurotoxicity
62
what are microglia?
resident macrophages of the brain and spinal cord that act as the first and main form of active immune defense. a class of glial cell
63
what are neuroglia, or glial cells?
non-neuronal cells that maintain homeostasis, form myelin, and provide support and protection for the brain and nervous system
64
what is an astrocyte?
a characteristically star-shaped glial cell providing various forms of support and protection for the brain and nervous system
65
2 non-genetic ABeta level elevators include
- general neuronal electrical activity
| - synaptic activity with enhanced vesicle exocytosis
66
3 genetic ABeta level elevators include
- APP mutations
- APP duplication
- apolipoprotein E4 allele
67
T/F ABeta aggregates increase synaptic efficiency
false -- ABeta aggregates decrease synaptic efficiency and cause Alzheimer's
68
with what protein does g-secretase complex in order to cleave APP?
presenilin
69
what is the hydrolytic complex that cleaves the C-end of the APP derived ABeta protein?
presenilin g-secretase complex
70
does APP cleavage by presenilin g-secretase complex always result in b-amyloid proteins?
no -- b and g-secretase cleavage results in ABeta;
| alpha and gamma secretase cleavage results in non-toxic p3 protein
71
of a, b, and g, which secretases cleave APP into ABeta at the N-terminus? at the C-terminus?
a and b - N-terminus
| g - c-terminus
72
T/F beta amyloid proteins are exocytosed into the synaptic cleft of neurons
true
73
alpha 1-antitrypsin can cause these two conformational diseases
emphysema and cirrhosis
74
emphysema and cirrhosis can be caused by conformational disease of what protein?
alpha 1-antitrypsin
75
emphysema is a disease of what organ characterized by what
emphysema is a chronic progressive lung disease characterized by abnormal permanent enlargement of airspaces due to alveolar wall destruction
76
T/F emphysema is an acute disease of the lung
false -- it is a chronic progressive lung disease characterized by abnormal permanent enlargement of airspaces due to alveolar wall destruction
77
what percentage of emphysema cases are caused by smoking and what percentage is caused by defective a-1-antitrypsin?
98-99% smoking, 1-2% conformational disease
78
what is the specific function of alpha 1-antitrypsin?
inhibit a host of porteolytic enzymes (e.g. neutrophil elastace)
79
what is the function of neutrophil elastase?
cleave elastin fibers (aka clears up inflammatory response)
80
how is emphysema caused by conformational disease?
misfolding of alpha 1-antitrypsin prevents it from inhibiting neutrophil elastase which leads to excess cleavage of elastin fibers in the lung and alveolar wall inflexibility (permanent enlargement.. difficulty breathing in and out and bringing oxygen into lungs)
81
what are 2 common variants of alpha 1-antitrypsin mutation that causes emphysema?
S (Glu264 -> Val)
| Z (Glu342 -> Lys)
82
the "S" variant of the alpha 1-antitrypsin mutation that causes emphysema replaces what aa with what aa?
Glu264 -> Val
83
the "Z" variant of the alpha 1-antitrypsin mutation that causes emphysema replaces what aa with what aa?
Glu342 -> Lys
84
which cleaves APP first, a/b secretases or presinilin g-secretase complex?
alpha and beta secretases cleave APP first, then presinilin gamma-secretase complex
85
T/F the common deficient variants of a-1-antitrypsin result from point mutations
true
S (Glu264 -> Val)
Z (Glu342 -> Lys)
86
T/F S a1-antitrypsin is associated with severe pulmonary sequelae?
false - Z a1-antitrypsin is severe in the lungs
87
T/F Z a1-antitrypsin is associated with severe pulmonary sequelae?
true
88
is the Glu264 -> Val mutation in a1-antitrypsin associated with severe pulmonary sequelae?
no - S (Glu264 -> Val) not severe in lungs
89
is the Glu342 -> Lys mutation in a1-antitrypsin associated with severe pulmonary sequelae?
yes - Z (Glu342 -> Lys) is severe in lungs
90
name one point mutation in a1-antitrypsin that is associated with severe pulmonary sequelae, and one that is not severe
Z (Glu342 -> Lys) - severe in lungs
| S (Glu264 -> Val) - not severe in lungs
91
by what 2 mechanisms does smoking cause emphysema?
-inflammatory reaction in airways
-inactivation of a1-antitrypsin -> overactivity of neutrophil elastase
(don't these two effects counteract each other? ask someone?)
92
describe how Z a1-antitrypsin causes emphysema vs liver disease?
- defective Z a1-antitrypsin are degraded or retained in ER of hepatocytes where they cause problems
- never makes it to lung to inhibit neutrophil elastase, lose elastic fibers in the lung
93
where is a1-antitrypsin synthesized?
liver (mainly)
| macrophages (to a lesser degree)
94
what is the molecular mechanism that causes aggregation of Z a1-antitrypsin?
distortion of tertiary structure causes the reactive center loop (which contains a b-stretch) to lock into the b-sheet A domain of another molecule (among the other b-stretches) and dimerize and further polymerize by the same mechanism with other Z a1-antitrypsin monomers
95
T/F Z a1-antitrypsin causes an inflammatory response in the lung
false -- Z a1-antitrypsin never makes it to the lung, it is degraded in liver where it is produced or accumulated in ER of hepatocytes
96
T/F Z a1-antitrypsin causes b-amyloid plaques in the liver
false -- b-amyloid plaques are formed extracellularly. intracellularly, such aggregations are called inclusion bodies or intracellular inclusions
97
what are the consequences of Z a1-antitrypsin aggregation within hepatocytes?
- hepatitis (inflammation of the liver)
- cirrhosis (fibrous scarring of the liver)
- hepatoma (hepatocellular carcinoma aka cancer)
98
where does an elastase enzyme react with a1-antitrypsin?
at the reactive center loop (which contains a b-stretch)
99
what is the normal molecular function of aq-antitrypsin?
elastase binds to reactive center loop; reactive center loop swings shut like mousetrap from top pole to bottom pole, incorporating rc loop b-strand into b-sheet A of a1-antitrypsin, deactivating elastase
100
T/F in Z a1-antitrypsin, the b-strand of the reactive center loop of one monomer inserts itself into the b-sheet A of another Z a1-antitrypsin monomer where it would usually swing shut on itself
true
101
T/F gene therapy is one possible treatment for emphysema, cirrhosis, hepatitis, and hepatomas caused by Z a1-antitrypsin
true - take out defective proteins, re-engineer genes so they are correct, reinsert
102
what is the normal function of a prion protein?
normal function presently unknown. it is a transmembrane glycoprotein normally found
at the surface of certain cells (e.g., neural and
hemoatopoietic stem cells)
103
how is a prion disease different form a bacterial or viral disease?
in bacterial and viral diseases, the infectious agent contains genetic material. a prion is just an infectous protein.
104
T/F a prion disease changes the conformation of a prioin protein form primarily b-sheets to primarily a-helices
false - other way around primarily a-helices to b-sheets
105
T/F bovine spongiform encephalopathies are believed to be caused by prion misfolding
true - mad cow is believed to be a prion disease
106
what are the names of the native and diseased prion isoforms?
```
PrP^C = prion (cellular)
PrP^Sc = prion (scrapie)
```
107
do PrP^C and PrP^Sc have the same primary sequence?
yes - different secondary and tertiary structures
108
in what kind of protein misfolding disease are the a-helices of normal proteins converted to b-sheets of pathologic proteins?
prion disease (PrP^Sc)
109
how does PrP^Sc convert PrP^C?
PrP^Sc acts as a catalyst to stabilize the PrP^Sc isoform over the PrP^C isoform in other proteins
110
which protein misfolding disease can be remembered as a "gangster recruiting" disease?
prion disease. one PrP^Sc recruits other, previously functional PrP^C proteins to become PrP^Sc and misbehave together
111
in what kind of cells, and where in the cells, are normal prion proteins found?
they are transmembrane glycoproteins normally found at the surface of certain cells (e.g., neural and hemoatopoietic stem cells)
112
PrP^C is dominated by what kind of secondary structure?
a-helices
113
PrP^Sc is dominated by what kind of secondary structure?
b-sheets
114
how do PrP^C and PrP^Sc differ in terms of solubility and protease degradation?
PrP^C - soluble, degradable
| PrP^Sc - largely insoluble, difficult to degrade
115
why is the pathological form of PrP called a "scrapie" ?
from the original discovery -- affected sheep and goats would compulsively "scrape" themselves on fences and rocks
116
which is caused by prion disease, Creutzfeldt–Jakob disease (CJD) or bovine spongiform encephalopathies (BSE) ?
both, CJD is the human version of mad cow disease both are degenerative neurological disorders caused by misfolded prions
117
what are the symptomatic consequences of prion disease?
PrP^Sc aggregate and form amyloid plaques, and kill the surrounding tissue (eg brain tissue), causing a host of neurological symptoms including dementia
118
T/F excessive production, decreased clearance, mutations, extreme pH, failure of chaperone systems, and age can all predispose prions proteins to disease
true
119
does prion disease cause inclusion bodies or amyloidosis?
aggregate prions form extracellular amyloids, not intracellular inclusion bodies
120
T/F is the Z a1-antitrypsin inheritance pattern autosomal recessive?
true
121
T/F a heterozygous carrier of the Z a1-antitrypsin mutation will express the disease phenotype (emphysema, cirrhosis, etc)
false -- the inheritance pattern is autosomal recessive, so only a homozygous carrier will express the disease phenotype
